Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBASK.L Regulatory News (BASK)

  • There is currently no data for BASK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment, Proposed Acquisition and Suspension

27 Jan 2020 07:30

RNS Number : 9253A
Baskerville Capital PLC
27 January 2020
 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain

 

BASKERVILLE CAPITAL PLC

("Baskerville" or the "Company")

 

Investment, Proposed Acquisition and Suspension of Listing

 

Baskerville is pleased to announce the completion of the acquisition of a 7.83% shareholding in Oberon Investments Limited ("Oberon") for £850,640 in cash ("Investment"), together with a commitment to subscribe for a further £350,945 worth of Oberon shares by no later than 30 April 2020.

 

Oberon is the holding company of MD Barnard & Co Limited (trading as Oberon Investments), an FCA regulated fund manager, see www.oberoninvestments.com. The Investment has been made by Baskerville to assist Oberon in funding and accelerating its acquisition strategy.

 

In addition to the Investment, Baskerville and Oberon have entered into non-legally binding heads of agreement providing for the acquisition by Baskerville of the entire issued share capital of Oberon not already owned by it ("Proposed Acquisition"). The purchase price of the Proposed Acquisition will be satisfied by the allotment and issue to the sellers of Oberon of new ordinary shares in Baskerville.

 

The Proposed Acquisition is subject to legal, financial and other due diligence and entry into a legally binding agreement. As no binding agreement has been reached, the Company cannot guarantee that the Proposed Acquisition will complete.

 

On completion of the Proposed Acquisition, it is the Company's intention to seek admission to trading on the NEX Exchange Growth Market ("NEX") although the Company reserves the option to apply for re-admission to the Standard segment of the Main Market or to AIM.

 

As Baskerville is a cash shell, the Investment is deemed to be a reverse takeover under the Listing Rules. Where a reverse takeover is contemplated but has not been completed, the FCA will normally suspend a company's listing pending the publication of a prospectus and then cancel the existing listing on completion of the reverse ahead of a new listing. The Company has requested from the FCA a suspension of its listing with immediate effect.

 

The Company is working to complete the Proposed Acquisition as soon as possible, together with an application to NEX.

 

Rodger Sargent, Chairman of Baskerville said: "Oberon has made tremendous progress in the last two years. We are delighted to become part of their success, with this initial investment and agreement to acquire Oberon.

 

"We believe Oberon can consolidate the booming yet disparate and fragmented UK small fund manager market. Becoming a quoted entity through this reverse acquisition will give Oberon access to the capital markets, accelerating its ambitions of becoming one of the UK's pre-eminent small fund managers.

 

"We will update as soon as possible with developments of the Proposed Acquisition and re-listing, which we aim to complete by early Q2 2020."

 

For information please contact:

Rodger Sargent

via Walbrook PR

 

Walbrook PR Ltd

Tel: 020 7933 8780 or baskerville@walbrookpr.com

Nick Rome

Tom Cooper

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBIGDBSGDDGGS
Date   Source Headline
8th Feb 202111:00 amRNSResult of General Meeting
26th Jan 20211:03 pmRNSDocuments for Inspection
21st Jan 20216:10 pmRNSProposed Acquisition of Oberon Investments
7th Jan 20212:34 pmRNSCancellation of Listing & Admission to Aquis
28th Oct 20202:15 pmRNSFinal Results
8th Jul 20207:00 amRNSUpdate on Proposed Acquisition
3rd Mar 20209:37 amRNSHalf-year Report
27th Jan 20207:30 amRNSInvestment, Proposed Acquisition and Suspension
28th Nov 20191:07 pmRNSResult of AGM
24th Oct 201912:07 pmRNSFinancial results for the year ended 30 June 2019
27th Aug 20197:00 amRNSExtension of exercise period of warrants
27th Mar 201911:35 amRNSHalf-year Report
5th Oct 20187:00 amRNSFinal Results
10th May 20187:00 amRNSHalf-year Report
6th Nov 201711:30 amRNSHolding(s) in Company
3rd Oct 201710:04 amRNSDirector/PDMR Shareholding
22nd Sep 20178:00 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.